» Authors » Karolina Bogatko

Karolina Bogatko

Explore the profile of Karolina Bogatko including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 8
Citations 61
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Szopa A, Bogatko K, Serefko A, Herbet M, Ostrowska-Lesko M, Wrobel A, et al.
Pharmacol Rep . 2024 Jul; 76(5):1012-1031. PMID: 39048810
Background: The objective of the study was to ascertain the antidepressant potential of the co-administration of NMDA receptor ligands and selective adenosine A1 and A2A receptor antagonists. Methods: The forced...
2.
Szopa A, Herbet M, Poleszak E, Bogatko K, Ostrowska-Lesko M, Swiader K, et al.
Metabolites . 2022 Jul; 12(7). PMID: 35888708
The main goal of this study was to determine the antidepressant-like potential of the co-administration of sodium selenite (Se) and the selective adenosine A1 and A2A antagonists DPCPX and istradefylline...
3.
Szopa A, Bogatko K, Herbet M, Serefko A, Ostrowska M, Wosko S, et al.
Int J Mol Sci . 2021 Mar; 22(4). PMID: 33673282
The purpose of the study was to investigate whether the co-administration of Mg and Zn with selective A1 and A2A receptor antagonists might be an interesting antidepressant strategy. Forced swim,...
4.
Szopa A, Bogatko K, Serefko A, Wyska E, Wosko S, Swiader K, et al.
Pharmacol Rep . 2019 Jun; 71(4):676-681. PMID: 31200233
Background: Adenosine, an endogenous nucleoside, modulates the release of monoamines, e.g., noradrenaline, serotonin, and dopamine in the brain. Both nonselective and selective stimulation of adenosine receptors produce symptoms of depression...
5.
Poleszak E, Szopa A, Bogatko K, Wyska E, Wosko S, Swiader K, et al.
Neurotox Res . 2018 Sep; 35(2):344-352. PMID: 30267268
Unsatisfactory therapeutic effects of currently used antidepressants force to search for new pharmacological treatment strategies. Recent research points to the relationship between depressive disorders and the adenosinergic system. Therefore, the...
6.
Szopa A, Poleszak E, Bogatko K, Wyska E, Wosko S, Doboszewska U, et al.
Naunyn Schmiedebergs Arch Pharmacol . 2018 Aug; 391(12):1361-1371. PMID: 30094458
The main goal of the present study was to evaluate the influence of the adenosine A1 receptor (A1R) antagonist - DPCPX - on depressive-like behavior in mice, as well as...
7.
Bogatko K, Poleszak E, Szopa A, Wyska E, Wlaz P, Swiader K, et al.
J Pharm Pharmacol . 2018 Jun; 70(9):1200-1208. PMID: 29943503
Objective: The main goal of our study was to investigate whether a selective antagonism of the adenosine A or A receptors is able to enhance the antidepressant activity of commonly...
8.
Poleszak E, Szopa A, Wyska E, Kukula-Koch W, Serefko A, Wosko S, et al.
Pharmacol Rep . 2016 Jan; 68(1):56-61. PMID: 26721352
Background: The main goal of this research was an evaluation of the influence of caffeine on the activity of mianserin and agomelatine. Methods: The mouse forced swim test and tail...